What This Bill Does · Plain English
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Frequently Asked Questions
Did HR.5708 pass?
HR.5708 did not pass and is no longer active. Final stage: COMMITTEE.
Full Bill Text
118 HR 5708 IH: MCM PRV Reauthorization Act U.S. House of Representatives 2023-09-26 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 118th CONGRESS 1st Session H. R. 5708 IN THE HOUSE OF REPRESENTATIVES September 26, 2023 Mr. Finstad (for himself and Mr. Phillips ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats. 1. Short title This Act may be cited as the MCM PRV Reauthorization Act . 2. Extension of priority review to encourage treatments for agents that present national security threats Section 565A(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–4a(g)) is amended by striking 2023 and inserting 2033 .
Loading intelligence layer…